Guido J. Falcone, ScD, MPH
Associate Professor of NeurologyCards
About
Titles
Associate Professor of Neurology
Academic Chief, Division of Neurocritical Care, Neurology; Director of Clinical Research in Neurocritical Care, Neurology; Training Director, Yale/AHA Bugher Center for Intracerebral Hemorrhage Research, Neurology; Staff Neurointensivist, Neurology
Biography
I am a Neurologist with subspecialty training in Neurocritical Care and Stroke, and an Epidemiologist with expertise in Population Genetics and Big Data. While on clinical duties, I treat critically ill patients that have sustained a significant neurological injury due to ischemic stroke, subarachnoid hemorrhage, intraparenchymal hemorrhage, traumatic brain injury, seizures, recent neurosurgery, decompensated neuromuscular diseases, and several others.
My research lies at the interphase of clinical neurology, neuroimaging, population genetics and genomic medicine. I am interested in understanding how common and rare genetic variation influences the occurrence, severity, functional outcome and recurrence of stroke, both hemorrhagic and ischemic. Genetic variants influencing these phenotypes can be used for numerous applications, including: (1) identification of novel biological mechanisms involved in causing stroke and determining its severity and outcome, (2) answering non-genetic epidemiological questions using gene mutations as instruments (in the statistical sense of the word), and (3) risk stratification of patients according to their genetic profile. Through the International Stroke Genetics Consortium, I work in close collaboration with numerous investigators interested in stroke genomics from around the world.
Appointments
Neurology
Associate Professor on TermPrimary
Other Departments & Organizations
- Center for Brain & Mind Health
- Center for Neuroepidemiology and Clinical Neurological Research
- Neurocritical Care & Emergency Surgery
- Neurology
- Yale Center for Genomic Health
- Yale Medicine
- Yale New Haven Health System
- Yale-BI Biomedical Data Science Fellowship
Education & Training
- Neurocritical Care Fellowship
- Harvard Medical School / Massachusetts General Hospital / Brigham and Women's Hospital
- ScD
- Harvard School of Public Health, Department of Epidemiology
- MPH
- Harvard School of Public Health, Quantitative Methods
- Neurology Residency
- F.L.E.N.I.
- MD
- University of Buenos Aires
Research
Publications
2026
Discovery Proteomics Using Data Independent Acquisition-based Mass Spectrometry Nominate Biomarkers of Stroke Diagnosis (S25.009)
Misra S, Jang W, Herrera S, Torres-Lopez V, Caglayan P, Falcone G, Sansing L, Rangaraju S. Discovery Proteomics Using Data Independent Acquisition-based Mass Spectrometry Nominate Biomarkers of Stroke Diagnosis (S25.009). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000215639.Peer-Reviewed Original ResearchImprovements in Biological Age Acceleration Lead to Better Neuroimaging, Clinical, and Cognitive Markers of Brain Health (S10.003)
Rivier C, Huo S, Clocchiatti-Tuozzo S, Renedo D, Sheth K, Falcone G. Improvements in Biological Age Acceleration Lead to Better Neuroimaging, Clinical, and Cognitive Markers of Brain Health (S10.003). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000215890.Peer-Reviewed Original ResearchNeighborhood Deprivation and Disparities in Blood Pressure Monitoring in Patients with Intracerebral Hemorrhage (P4-4.018)
Namian S, Smith J, Constantinescu S, Tawaldemedhen Y, Rivier C, Clocchiatti-Tuozzo S, Huo S, Wu K, Forman R, Torres-Lopez V, Sunmonu N, Petersen N, Falcone G. Neighborhood Deprivation and Disparities in Blood Pressure Monitoring in Patients with Intracerebral Hemorrhage (P4-4.018). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000216140.Peer-Reviewed Original ResearchMulti-trait Polygenic Profiling and Dementia- and Disability-free Survival: Results from the Health and Retirement Study (P5-13.001)
Tawaldemedhen Y, Clocchiatti-Tuozzo S, Rivier C, Huo S, Gill T, Falcone G. Multi-trait Polygenic Profiling and Dementia- and Disability-free Survival: Results from the Health and Retirement Study (P5-13.001). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000216565.Peer-Reviewed Original ResearchDiscovery Proteomics Using Data Independent Acquisition-based Mass Spectrometry Nominate Biomarker Candidates of Atrial Fibrillation in Stroke (P4-5.016)
Jang W, Misra S, Herrera S, lopez V, Caglayan P, Sharma R, Falcone G, Sansing L, Rangaraju S. Discovery Proteomics Using Data Independent Acquisition-based Mass Spectrometry Nominate Biomarker Candidates of Atrial Fibrillation in Stroke (P4-5.016). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000216874.Peer-Reviewed Original ResearchProteogenomic Integration Reveals Paralemmin-1 as a Mediator of Increased Intracerebral Hemorrhage Risk in APOE ɛ4 Carriers (S10.008)
Huo S, Clocchiatti-Tuozzo S, Rangaraju S, Murthy S, Payabvash S, Rivier C, Falcone G. Proteogenomic Integration Reveals Paralemmin-1 as a Mediator of Increased Intracerebral Hemorrhage Risk in APOE ɛ4 Carriers (S10.008). Neurology 2026, 106 DOI: 10.1212/wnl.0000000000217189.Peer-Reviewed Original ResearchCytokine markers in intracerebral hemorrhage are linked to ventricular imaging and outcomes
Sorensen G, Grychowski L, Yan J, Remillard W, Lidman A, Edwards T, Herman A, Johnson C, Sheth K, Matouk C, Falcone G, Gilmore E, Payabvash S, Sansing L, Magid-Bernstein J. Cytokine markers in intracerebral hemorrhage are linked to ventricular imaging and outcomes. Journal Of Stroke And Cerebrovascular Diseases 2026, 35: 108663. PMID: 42167563, PMCID: PMC13292057, DOI: 10.1016/j.jstrokecerebrovasdis.2026.108663.Peer-Reviewed Original ResearchConceptsAssociated with ventricular enlargementModified Rankin ScaleExternal ventricular drainIntracerebral hemorrhage patientsCentral nervous systemIntracerebral hemorrhageCerebrospinal fluidVentricular enlargementComputed tomographyFunctional outcomesInterleukin-6Interleukin-8Granulocyte colony-stimulating factorCentral nervous system inflammationCC motif chemokine ligand 2Cerebrospinal fluid cytokinesVascular endothelial growth factor AMotif chemokine ligand 2Colony-stimulating factorBiomarkers of disease progressionEndothelial growth factor ACentral inflammatory responseChemokine ligand 2Growth factor AVentricular volume changesGenetic predisposition to diabetes and risk of stroke in a Native Hawaiian population
Brown S, Both C, Kanaʻiaupuni M, Dowsett L, Fox K, Nakagawa K, Gerschenson M, Falcone G. Genetic predisposition to diabetes and risk of stroke in a Native Hawaiian population. Journal Of Diabetes & Metabolic Disorders 2026, 25: 130. PMID: 42111465, PMCID: PMC13153298, DOI: 10.1007/s40200-026-01940-5.Peer-Reviewed Original ResearchGenetic predisposition to diabetesPolygenic risk scoresRisk of strokePredisposition to diabetesGenetic variantsRisk of developing diabetesRisk scoreGenome-wide significance levelPublic health strategiesNative Hawaiian populationHigh riskLogistic regression modelsHigh risk of strokeAssociated with diabetesHealth QuestionnairePopulation ArchitectureHealth strategiesHeritable risk factorsStroke casesEffect modifiersStroke patientsCase/control studyRisk factorsSex-matched control subjectsCerebrovascular diseaseFunctional Outcomes After Intensive Blood Pressure Reduction in Deep and Lobar Intracerebral Hemorrhage
Clocchiatti-Tuozzo S, Qureshi A, Rivier C, Huo S, Matouk C, Payabvash S, Murthy S, Sheth K, Rabinstein A, Falcone G, Hawkes M. Functional Outcomes After Intensive Blood Pressure Reduction in Deep and Lobar Intracerebral Hemorrhage. Neurology 2026, 106: e214860. PMID: 41962119, DOI: 10.1212/wnl.0000000000214860.Peer-Reviewed Original ResearchConceptsLobar intracerebral hemorrhageIntensive BP reductionIntensive Blood Pressure ReductionATACH-2Intracerebral hemorrhage locationBP reductionBlood pressure reductionIntracerebral hemorrhageDeep intracerebral hemorrhagePoor functional outcomeRandomized clinical trialsFunctional outcomesBlood pressureRisk of poor functional outcomeModified Rankin Scale scoreAcute intracerebral hemorrhageMeta-analysisPressure reductionIntensive blood pressureRankin Scale scoreAcute cerebral hemorrhageClinically distinct subtypesIndividual patient dataHematoma locationExposure of interestCharacterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Wang E, Misra S, Yan J, Chook P, Kawamura Y, Kitagawa R, Kim J, Gilmore E, de Havenon A, Sivaraju A, Hirsch L, Falcone G, Rangaraju S, Sansing L, Magid-Bernstein J, Mishra N. Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication. PLOS ONE 2026, 21: e0345752. PMID: 41915645, PMCID: PMC13038000, DOI: 10.1371/journal.pone.0345752.Peer-Reviewed Original ResearchConceptsIntracerebral hemorrhage volumeDays post-ICHIntracerebral hemorrhageLobar intracerebral hemorrhagePost-stroke seizuresPost-ICHCCL2 levelsEpileptiform dischargesInflammatory biomarkersMultivariate analysisOdds ratioAssociated with poor outcomesMultivariate logistic regression analysisCytometric bead arrayRetrospective cohort studyYale-New Haven HospitalPlasma biomarker levelsLogistic regression analysisClinical seizuresOutcome prognosticationNew Haven HospitalUnivariate analysisPoor outcomeBead arrayCohort study
Clinical Trials
Current Trials
Brain Oxygen Optimization in Severe TBI, Phase 3 (BOOST3)
IRB ID2000024956RoleSub InvestigatorPrimary Completion Date07/01/2023Recruiting ParticipantsGenderBothAge14+ yearsAnticoagulation for Stroke Prevention and Recovery After ICH (ASPIRE)
IRB ID2000026409RolePrincipal InvestigatorPrimary Completion Date04/30/2028Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
Clinical Care
Overview
Guido Falcone, MD, ScD, MPH, is a critical care neurologist who treats patients with severe brain injuries from trauma, strokes, hemorrhages, and seizures, among other conditions. “I usually meet patients with these injuries immediately after they come to the hospital,” Dr. Falcone says. He also sees patients suffering from symptoms caused by neuromuscular diseases or complications from brain surgery.
“One important characteristic of our specialty is that many important decisions need to be made in those initial few minutes to hours,” Dr. Falcone says. “We also need to factor in the patient’s wishes, but often they are unconscious and cannot communicate.”
In those cases, Dr. Falcone relies on the patient’s family for guidance. “This can cause a tremendous amount of stress as they carry the huge responsibility of representing their loved ones,” he says.
Dr. Falcone keeps this additional stress in mind when he’s talking with the patient’s family about a diagnosis and what to expect next. “It’s very important for us to be honest and explain to them what we know and don’t know so that this uncertainty can be taken into consideration when we’re making a clinical decision,” he says. Dr. Falcone says he and his colleagues in the Neuroscience Intensive Care Unit (Neuro ICU) frequently update families on the status of a patient’s condition and progress.
“Something I came to realize after a few years in the field is that we help patients and families all the time. Sometimes, we help them get better,” Dr. Falcone says. “But another important part of our job is to give the very best end-of-life care, with the same approach we use when curing a disease or saving lives, if that is necessary.”
In his research, Dr. Falcone specializes in population genetics and genomic medicine, two related fields that involve analyzing large amounts of data and searching for different variants of genes that might influence human disease. He works with a team that uses information from across disciplines, such as neuroimaging data, for example, to conduct studies. “We want to use data to understand not just what causes disease, but also who is at high risk of developing it,” Dr. Falcone says. “Genes are such a powerful tool in patient care because our genetic information is constant from birth.”
Clinical Specialties
News & Links
News
- December 04, 2025
At Yale, Rigorous Research Sets Stroke Treatments Up for Success
- August 21, 2025
Study Ties Genetics and Common Anticoagulant to Risk of Intracranial Hemorrhage
- July 05, 2023
Cyprien Rivier, MD, MSc Wins ESOC Young Research Investigator Award in Stroke
- February 08, 2023
Santiago Clocchiatti-Tuozzo, MD Honored with Bernard J. Tyson Career Development Award and Stroke Underrepresented Racial and Ethnic Groups Travel Grant
Get In Touch
Contacts
Locations
100 York Street
Academic Office
Fl 1, Ste 1E
New Haven, CT 06511
Business Office
203.785.6288Business Office Fax
203.737.4419Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.